ATE133075T1 - Verwendung von antikörper gegen angiogenin: immunotherapeutische mittel - Google Patents
Verwendung von antikörper gegen angiogenin: immunotherapeutische mittelInfo
- Publication number
- ATE133075T1 ATE133075T1 AT88907537T AT88907537T ATE133075T1 AT E133075 T1 ATE133075 T1 AT E133075T1 AT 88907537 T AT88907537 T AT 88907537T AT 88907537 T AT88907537 T AT 88907537T AT E133075 T1 ATE133075 T1 AT E133075T1
- Authority
- AT
- Austria
- Prior art keywords
- angiogenin
- antibodies
- immunotherapeutic agents
- angiogenesis
- fragment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
- Y10S530/809—Fused cells, e.g. hybridoma
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/083,231 US4853219A (en) | 1987-08-06 | 1987-08-06 | Antibodies to angiogenin: immunotherapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE133075T1 true ATE133075T1 (de) | 1996-02-15 |
Family
ID=22177021
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88907537T ATE133075T1 (de) | 1987-08-06 | 1988-08-05 | Verwendung von antikörper gegen angiogenin: immunotherapeutische mittel |
Country Status (13)
Country | Link |
---|---|
US (1) | US4853219A (de) |
EP (1) | EP0436526B1 (de) |
JP (1) | JPH02504512A (de) |
KR (1) | KR920005691B1 (de) |
AT (1) | ATE133075T1 (de) |
AU (1) | AU618024B2 (de) |
CA (1) | CA1341425C (de) |
DE (1) | DE3854926T2 (de) |
DK (1) | DK29490A (de) |
ES (1) | ES2015349A6 (de) |
GR (1) | GR1000430B (de) |
PT (1) | PT88314A (de) |
WO (1) | WO1989000862A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5520914A (en) * | 1987-08-06 | 1996-05-28 | President And Fellows Of Harvard College | Antibodies to angiogenin: immunotherapeutic agents |
FR2623509B1 (fr) * | 1987-11-19 | 1990-04-20 | Centre Nat Rech Scient | Proteine de 17 kd a action angiogenique, son procede d'isolement a partir de lait de mammiferes, compositions therapeutiques la contenant, procede de detection et/ou de dosage et reactifs immunologiques de detection et de dosage des angiogenines de mammiferes, de leurs homologues et de leurs fragments |
US6929907B2 (en) * | 1999-12-31 | 2005-08-16 | North Carolina State University | Methods and compositions for determining the purity of chemically synthesized nucleic acids |
EP1399186B1 (de) | 2001-06-13 | 2009-11-18 | Armbruster Biotechnology GmbH | Arzneimittel zur behandlung von tumoren und deren metastasen unter verwendung eines bindemoleküls gegen das bone-sialoprotein |
AU2006291054B2 (en) * | 2005-09-12 | 2011-10-13 | The Brigham And Women's Hospital, Inc. | Recurrent gene fusions in prostate cancer |
CA2648947A1 (en) * | 2006-04-10 | 2007-11-15 | Fusion Antibodies Limited | Therapy targeting cathepsin s |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4229532A (en) * | 1978-12-29 | 1980-10-21 | Monsanto Company | Production of tumor angiogenesis factor by cell culture |
US4229531A (en) * | 1978-12-29 | 1980-10-21 | Monsanto Company | Production of tumor angiogenesis factor by cell culture |
US4273871A (en) * | 1980-03-03 | 1981-06-16 | Monsanto Company | Production of angiogenic factor by cell culture |
DE3110560A1 (de) * | 1981-03-18 | 1982-10-14 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | "angiotropine der leukozyten und des entzuendungsgewebes: eine neue klasse natuerlicher chemotropischer mitogene fuer das richtungswachstum von blutgefaessen und zur neovaskularisierung von geweben" |
DE3381236D1 (de) * | 1982-11-30 | 1990-04-05 | Univ Manchester | Produktion von angiogenen faktoren. |
US4529590A (en) * | 1982-12-27 | 1985-07-16 | Leveen Robert F | Production of angiogenetic factor |
US4503038A (en) * | 1983-02-25 | 1985-03-05 | The Regents Of The University Of California | Extracellular nonmitogenic angiogenesis factor and method of isolation thereof from wound fluid |
US4699788A (en) * | 1984-08-20 | 1987-10-13 | Trustees Of Boston University | Angiogenic factor methods of extraction and method for producing angiogenesis |
US4727137A (en) * | 1985-04-17 | 1988-02-23 | President And Fellows Of Harvard College | Purified protein having angiogenic activity and methods of preparation |
EP0234545A3 (de) * | 1986-02-24 | 1989-05-24 | Clemens Prof. Dr. Sorg | Gereinigter humaner Angiogenfaktor, Verfahren zu seiner Herstellung und pharmazeutische Präparate |
-
1987
- 1987-08-06 US US07/083,231 patent/US4853219A/en not_active Expired - Lifetime
-
1988
- 1988-08-05 WO PCT/US1988/002590 patent/WO1989000862A1/en active IP Right Grant
- 1988-08-05 JP JP63507001A patent/JPH02504512A/ja active Pending
- 1988-08-05 AU AU23166/88A patent/AU618024B2/en not_active Ceased
- 1988-08-05 EP EP88907537A patent/EP0436526B1/de not_active Expired - Lifetime
- 1988-08-05 AT AT88907537T patent/ATE133075T1/de active
- 1988-08-05 DE DE3854926T patent/DE3854926T2/de not_active Expired - Fee Related
- 1988-08-05 KR KR1019890700594A patent/KR920005691B1/ko not_active IP Right Cessation
- 1988-08-08 CA CA000574073A patent/CA1341425C/en not_active Expired - Fee Related
- 1988-08-19 PT PT88314A patent/PT88314A/pt unknown
- 1988-08-26 ES ES888802642A patent/ES2015349A6/es not_active Expired - Lifetime
-
1989
- 1989-08-03 GR GR890100489A patent/GR1000430B/el unknown
-
1990
- 1990-02-05 DK DK029490A patent/DK29490A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PT88314A (pt) | 1989-06-30 |
WO1989000862A1 (en) | 1989-02-09 |
JPH02504512A (ja) | 1990-12-20 |
ES2015349A6 (es) | 1990-08-16 |
DE3854926D1 (de) | 1996-02-29 |
GR1000430B (el) | 1992-07-30 |
EP0436526B1 (de) | 1996-01-17 |
KR920005691B1 (ko) | 1992-07-13 |
EP0436526A1 (de) | 1991-07-17 |
CA1341425C (en) | 2003-03-18 |
DK29490A (da) | 1990-03-30 |
KR890701130A (ko) | 1989-12-19 |
DE3854926T2 (de) | 1996-05-30 |
US4853219A (en) | 1989-08-01 |
AU2316688A (en) | 1989-03-01 |
EP0436526A4 (de) | 1990-08-20 |
DK29490D0 (da) | 1990-02-05 |
AU618024B2 (en) | 1991-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8206856A1 (es) | Mejoras en un metodo y su correspondiente equipo de ensayo para determinar antigenos por medio de una reaccion inmuno- quimica | |
NO934777D0 (no) | Tumor, karbohydratantigen spesifikt monoklonalt antistoff og cell elinje | |
DE69024659D1 (de) | Harnwegstumor-assoziiertes antigen, verwendung von antigenen untereinheiten und nachweisverfahren | |
ATE45285T1 (de) | Durch antiidiotype antikoerper induzierte immune antwort zu tumoren und viren. | |
NO302176B1 (no) | Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen | |
OA08485A (fr) | Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas. | |
AU525403B2 (en) | Purified antigen | |
FI922017A (fi) | Immunbestaemningar och monoklonala antikroppar foer protrombinaktiveringspeptider och degradations- produkter av dessa. | |
DE3586216D1 (de) | Brusttumorassoziiertes antigen und monoklonale antikoerper dazu. | |
ATE133075T1 (de) | Verwendung von antikörper gegen angiogenin: immunotherapeutische mittel | |
DE69026875T2 (de) | Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür | |
ATE87941T1 (de) | Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens. | |
EP0323802A3 (de) | Gegen Lungenkrebs gerichtete monoklonale Antikörper und Zelloberflächenantigen davon | |
EP0287397A3 (en) | Monoclonal antibody specific to human pancreatic phospholipase a2 | |
NO883854D0 (no) | Monoklonalt antistoff og fremgangsmaate for dets fremstilling. | |
DK329789A (da) | Monoklonalt antistof | |
DE69114546T2 (de) | Neue Verwendung für einen monoklonalen Antikörper. | |
DE3478346D1 (en) | Method for assaying basic fetoprotein and reagent therefor | |
ATE92081T1 (de) | Tumorassoziiertes antigen. | |
SE8704114D0 (sv) | Monoclonal antibody, a process for its preparation and the use thereof | |
SE8401946L (sv) | Antikropp mot human prostatacancer | |
FI961439A (fi) | Menetelmä terapeuttisesti käyttökelpoisen vasta-aineen tai vasta-ainefragmentin valmistamiseksi |